23andMe Teams Up with HealthEx to Integrate DNA Data and Medical Records
At the STAT Breakthrough Summit West, 23andMe announced a partnership with HealthEx, enabling users to connect their DNA data with their medical records.
At the STAT Breakthrough Summit West, 23andMe announced a partnership with HealthEx, enabling users to connect their DNA data with their medical records.
In a notable decision, Virginia's governor has vetoed legislation that sought to establish an advisory panel aimed at lowering prescription drug prices, impacting potential savings for residents.
A recently developed field-ready tool aims to improve the identification of parasitic nematodes, which are often missed by standard testing methods, potentially benefiting global health.
Researchers at Florida State University have made significant strides in drug discovery by synthesizing new molecules from bacteria sourced from a Pacific Ocean sea sponge, which could aid in developing treatments for rare cancers.
A recent analysis indicates that most Canadian medical societies do not have adequate conflict-of-interest policies, with many existing policies being fragmented and limited in scope.
Noncitizen immigrants, particularly those without documentation, face major challenges in accessing health coverage, leading to higher uninsured rates compared to citizens.
A recent analysis highlights the socioeconomic characteristics and health coverage of children from immigrant families, drawing from 2024 American Community Survey data.
This fact sheet provides an overview of health coverage for immigrants based on data from the 2023 KFF/LA Times Survey of Immigrants.
In a notable move, Maryland's State Affordability Board has established a price cap on Ozempic, joining nine other states exploring similar affordability measures for prescription drugs.
The Trump administration has announced a significant expansion of its drug discount platform, TrumpRx, adding 600 generic medications through partnerships with major online pharmacies.
Researchers at the University of Connecticut have developed a microneedle patch vaccine that could address significant challenges in agricultural vaccine distribution.
As the Ebola outbreak continues in the Democratic Republic of the Congo, experts are contemplating the testing of an unapproved vaccine, given the lack of approved options.
The recent rise in mining petitions in Peru has led to growing concerns about the underlying motivations and entities responsible for these applications.
The Trump administration's new policy may result in patients facing higher out-of-pocket health care costs as skimpier plans are permitted on ACA exchanges.
The 'tradwife' movement claims to empower women by embracing traditional roles. However, a deeper analysis reveals potential connections to far-right ideologies.
Research reveals that the first livestock herders in eastern Africa continued to engage in fishing, hunting, and gathering for up to 1,000 years after introducing cattle into their communities.
The merger between WakeMed and Atrium Health has been under wraps for two years, raising questions about its implications for healthcare delivery.
AstraZeneca has received FDA approval for its hypertension medication, marking a significant development in the biotech sector amid ongoing discussions about FDA leadership and other industry news.
In light of an ongoing Ebola outbreak, the U.S. has enacted a travel ban for individuals from certain affected regions, including the Democratic Republic of the Congo, Uganda, and South Sudan.
The Supreme Court's decision could complicate ongoing lawsuits from pharmaceutical companies regarding drug price negotiations.